Skip to main content

Table 2 Logistic regression analyses of factors related to AE

From: Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation

Variable

OR

95% CI

p-value

GAP stage, II and III

2.20

1.05–4.64

0.037

Ever smoker

3.05

0.38–24.23

0.292

Histology

 Adenocarcinoma

1.00

  

 Squamous cell carcinoma

0.60

0.26–1.36

0.220

 Others

1.04

0.35–3.11

0.950

NSCLC stage ≥ III

1.85

0.83–4.16

0.135

CPFE

2.26

1.09–4.69

0.029

  1. Values are presented as odds ratios (ORs) with 95% confidence intervals (CIs)
  2. Definition of abbreviation: GAP Score Gender–Age–Physiology Score, NSCLC Non-Small Cell Lung Cancer, CPFE Combined Pulmonary Fibrosis and Emphysema
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us